Measurement of the coherence length of atomic two-photon radiation

We report a novel method of determining the coherence length of photons produced in the two-photon decay of metastable atomic deuterium by observing the depolarization of the photons in what is essentially a true single-photon interference experiment. In the Stirling source two photons propagating in the ±z directions are detected in coincidence. The degree of polarization of the radiation emerging from a multiwave plate placed on one side of the source as a function of the optical path difference 6 introduced by the multiwave plate between the orthogonally polarized components is determined by measuring the Stokes' parameters. The results confirm the dependence of the depolarizing effect of the multiwave plate on 6, agree with the quantum mechanical predictions and allow a measurement to be made of the coherence length of single photons of the two-photon pair. We also report the results t>f an experiment which, for the first time, demonstrates the action of an achromatic half-wave plate on the polarization state of the two-photon radiation emitted by atomic deuterium in the metastable 2Sv, state The results agree with the quantum mechanical predictions and confirm the hypothesis of Breit and Teller that the fine and hyperfine interaction play no role in the emission process

Level of conus medullaris termination in adult Kashmiri population: a magnet resonance imaging-based study

Background: The spinal cord is considered as the principle content of vertebral canal. It begins as a downward extension of medulla oblongata at the level of upper border of first cervical vertebrae (C1). The terminal part of spinal cord is conical and is termed as conus medullaris. In adults the level of termination of conus medullaris varies between T12 to L3 vertebrae. The level of termination of conus medullaris is clinically important to avoid injuries during spinal anaesthesia and lumber puncture. Methods: The saggital magnetic resonance images of 168 patients were reviewed in the Department of Radiodiagnosis, Government Medical College, Srinagar from January 2022 to June 2022. The most caudal point of the cord was considered as the tip of conus medullaris. A line was drawn through the tip perpendicular to the long axis of spinal cord to determine its location with adjacent vertebra. Results: The level of conus medullaris termination was most commonly located at T12-L1 intervertebral disc level. The results revealed a significant statistical difference in levels of termination of conus medullaris with respect to age and sex. Conclusions: In literature, the highest level of conus medullaris termination is stated to be at T11-T12 Intervertebral disc and the lowest level at the body of L3 vertebra. Therefore, spinal anaesthesia and lumber puncture procedure should be done below L3 vertebral body in order to avoid iatrogenic complications

Chitosan nanoparticles: a versatile platform for biomedical applications

Chitosan is a biodegradable and biocompatible natural polymer that has been extensively explored in recent decades. The Food and Drug Administration has approved chitosan for wound treatment and nutritional use. Furthermore, chitosan has paved the way for advancements in different biomedical applications including as a nanocarrier and tissue-engineering scaffold. Its antibacterial, antioxidant, and haemostatic properties make it an excellent option for wound dressings. Because of its hydrophilic nature, chitosan is an ideal starting material for biocompatible and biodegradable hydrogels. To suit specific application demands, chitosan can be combined with fillers, such as hydroxyapatite, to modify the mechanical characteristics of pH-sensitive hydrogels. Furthermore, the cationic characteristics of chitosan have made it a popular choice for gene delivery and cancer therapy. Thus, the use of chitosan nanoparticles in developing novel drug delivery systems has received special attention. This review aims to provide an overview of chitosan-based nanoparticles, focusing on their versatile properties and different applications in biomedical sciences and engineering.info:eu-repo/semantics/publishedVersio

Ubiquitin-specific peptidase 37: an important cog in the oncogenic machinery of cancerous cells.

Protein ubiquitination is one of the most crucial posttranslational modifications responsible for regulating the stability and activity of proteins involved in homeostatic cellular function. Inconsistencies in the ubiquitination process may lead to tumorigenesis. Ubiquitin-specific peptidases are attractive therapeutic targets in different cancers and are being evaluated for clinical development. Ubiquitin-specific peptidase 37 (USP37) is one of the least studied members of the USP family. USP37 controls numerous aspects of oncogenesis, including stabilizing many different oncoproteins. Recent work highlights the role of USP37 in stimulating the epithelial-mesenchymal transition and metastasis in lung and breast cancer by stabilizing SNAI1 and stimulating the sonic hedgehog pathway, respectively. Several aspects of USP37 biology in cancer cells are yet unclear and are an active area of research. This review emphasizes the importance of USP37 in cancer and how identifying its molecular targets and signalling networks in various cancer types can help advance cancer therapeutics.This study was supported by AIIMS Intramural grant (Grant number: A514) and AIIMS IITD Grant (AI-34) from All India Institute of Medical Sciences (AIIMS) New Delhi, Delhi India to Mayank singh. Sidra Medicine Precision Program provides research funding to Mohammad Haris (5081012002). Muzafar A. Macha is supported by Ramalingaswami Fellowship (Grant number: D.O. NO.BT/HRD/35/02/2006) from the Department of Biotechnology, Govt. of India, New Delhi

Cowpea [Vigna unguiculata (L.) Walp] herbage yield and nutritional quality in cowpea-sorghum mixed strip intercropping systems

En los sistemas tradicionales de cultivo intercalado de frijol caupí y sorgo en franjas y filas, el rendimiento de forraje del frijol caupí se reduce significativamente debido a la intensa competencia y al dominio del sorgo en la adquisición de recursos para el cultivo. Este estudio de campo evaluó novedosos sistemas de cultivo intercalado en franjas mixtas de frijol caupí forrajero y sorgo con diferente número de filas de cultivo en diferentes disposiciones espaciales. El frijol caupí se intercaló con el sorgo en franjas de 8, 12 y 16 filas con un espaciamiento de 30, 45 y 60 cm entre las filas. En cada franja se mantuvo igual número de filas de frijol caupí y sorgo. Para la ejecución de los ensayos de campo durante las temporadas de verano de 2013 y 2014 se utilizó un diseño factorial en bloques completos aleatorizados con tres repeticiones. Las franjas con 12 filas y un espaciamiento de 60 cm entre las filas afectaron positivamente a todas las variables agronómicas del frijol caupí que condujeron al máximo rendimiento forrajero (22.2 y 23.7 t/ha en 2013 y 2014, respectivamente) y de biomasa de materia seca (6.63 y 6.94 t/ha en 2013 y 2014, respectivamente). En cambio, las franjas de 8 filas con un espaciamiento de 30 cm superaron a otros sistemas de cultivo intercalado al obtener el rendimiento máximo de hierba y de biomasa de materia seca del sorgo. El sistema de cultivo intercalado compuesto por franjas de 12 filas con un espaciamiento de 60 cm entre las filas siguió siendo superior, al registrar el contenido máximo de proteína bruta, grasas y cenizas junto con el mínimo contenido de fibra de frijol caupí. Además, este sistema de cultivo intercalado bajo el resto de las disposiciones espaciales también permaneció incomparable, mientras que las franjas de 16 filas bajo todas las geometrías de siembra permanecieron inferiores a otros sistemas de cultivo intercalado. Por lo tanto, el cultivo intercalado de frijol caupí con sorgo en franjas de 12 filas con un espaciado de 60 cm ofrece una solución biológicamente viable para mejorar la biomasa y la calidad del forraje del caupí en cultivo intercalado con sorgo.In traditional row and strip cowpea-sorghum intercropping systems, cowpea forage yield reduces significantly due to intense competition and dominance of sorghum in acquiring growth resources. This field study evaluated novel mixed strip intercropping systems of forage cowpea and sorghum having different number of crops rows arranged under different spatial arrangements. Cowpea was intercropped with sorghum in 8, 12 and 16 rows strips with row-row spacing of 30, 45 and 60 cm. In each strip, equal number of rows of cowpea and sorghum were maintained. Factorial arrangement of randomized complete block design with three replicates was used to execute the field trials during summer seasons of 2013 and 2014. Strips having 12 rows and 60 cm row-row spacing positively affected all agronomic variables of cowpea which led to maximum forage yield (22.2 and 23.7 t ha-1 during 2013 and 2014 respectively) and dry matter biomass (6.63 and 6.94 t ha-1 during 2013 and 2014 respectively). In contrast, 8-rows strips having line spacing of 30 cm outperformed other intercropping systems by yielding the maximum herbage yield and dry matter biomass of sorghum. The intercropping system comprising of 12-rows strips with 60 cm row-row spacing remained superior in recording the maximum crude protein, fats and total ash along with the minimum fiber content of cowpea. In addition, this intercropping system under rest of spatial arrangements also remained unmatched, while 16-rows strips under all planting geometries remained inferior to other intercropping systems. Thus, cowpea intercropping with sorghum in 12-rows strips having 60 cm spacing offers biologically viable solution to improve biomass and forage quality of cowpea in intercropping with sorghum

Bacterial plant biostimulants: A sustainable way towards improving growth, productivity, and health of crops

This review presents a comprehensive and systematic study of the field of bacterial plant biostimulants and considers the fundamental and innovative principles underlying this technology. Plant biostimulants are an important tool for modern agriculture as part of an integrated crop management (ICM) system, helping make agriculture more sustainable and resilient. Plant biostimulants contain substance(s) and/or microorganisms whose function when applied to plants or the rhizosphere is to stimulate natural processes to enhance plant nutrient uptake, nutrient use efficiency, tolerance to abiotic stress, biocontrol, and crop quality. The use of plant biostimulants has gained substantial and significant heed worldwide as an environmentally friendly alternative to sustainable agricultural production. At present, there is an increasing curiosity in industry and researchers about microbial biostimulants, especially bacterial plant biostimulants (BPBs), to improve crop growth and productivity. The BPBs that are based on PGPR (plant growth-promoting rhizobacteria) play plausible roles to promote/stimulate crop plant growth through several mechanisms that include (i) nutrient acquisition by nitrogen (N2) fixation and solubilization of insoluble minerals (P, K, Zn), organic acids and siderophores; (ii) antimicrobial metabolites and various lytic enzymes; (iii) the action of growth regulators and stress-responsive/induced phytohormones; (iv) ameliorating abiotic stress such as drought, high soil salinity, extreme temperatures, oxidative stress, and heavy metals by using different modes of action; and (v) plant defense induction modes. Presented here is a brief review emphasizing the applicability of BPBs as an innovative exertion to fulfill the current food crisis

Effect of quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome

IntroductionPolycystic Ovary syndrome (PCOS) affects the health of many women around the world. Apart from fundamental metabolic problems connected to PCOS, focus of our study is on the role of quercetin on genes relevant to steroidogenesis and folliculogenesis.MethodsEighteen mature parkes strain mice (4-5 weeks old) weighing 18–21 g were randomly divided into three groups of six each as follows: Group I serves as the control and was given water and a regular chow diet ad lib for 66 days; group II was given oral gavage administration of letrozole (LETZ) (6 mg/kg bw) for 21 days to induce PCOS and was left untreated for 45 days; For three weeks, Group III received oral gavage dose of LETZ (6 mg/kg), after which it received Quercetin (QUER) (125 mg/kg bw orally daily) for 45 days.ResultsIn our study we observed that mice with PCOS had irregular estrous cycle with increased LH/FSH ratio, decreased estrogen level and decline in expression of Kitl, Bmp1, Cyp11a1, Cyp19a1, Ar, lhr, Fshr and Esr1 in ovary. Moreover, we observed increase in the expression of CYP17a1, as well as increase in cholesterol, triglycerides, testosterone, vascular endothelial growth factor VEGF and insulin levels. All these changes were reversed after the administration of quercetin in PCOS mice.DiscussionQuercetin treatment reversed the molecular, functional and morphological abnormalities brought on due to letrozole in pathological and physiological setting, particularly the issues of reproduction connected to PCOS. Quercetin doesn’t act locally only but it acts systematically as it works on Pituitary (LH/FSH)- Ovary (gonad hormones) axis. the Side effects of Quercetin have to be targeted in future researches. Quercetin may act as a promising candidate for medical management of human PCOS

Characterization of a new full length TMPRSS3 isoform and identification of mutant alleles responsible for nonsyndromic recessive deafness in Newfoundland and Pakistan

BACKGROUND: Mutant alleles of TMPRSS3 are associated with nonsyndromic recessive deafness (DFNB8/B10). TMPRSS3 encodes a predicted secreted serine protease, although the deduced amino acid sequence has no signal peptide. In this study, we searched for mutant alleles of TMPRSS3 in families from Pakistan and Newfoundland with recessive deafness co-segregating with DFNB8/B10 linked haplotypes and also more thoroughly characterized the genomic structure of TMPRSS3. METHODS: We enrolled families segregating recessive hearing loss from Pakistan and Newfoundland. Microsatellite markers flanking the TMPRSS3 locus were used for linkage analysis. DNA samples from participating individuals were sequenced for TMPRSS3. The structure of TMPRSS3 was characterized bioinformatically and experimentally by sequencing novel cDNA clones of TMPRSS3. RESULTS: We identified mutations in TMPRSS3 in four Pakistani families with recessive, nonsyndromic congenital deafness. We also identified two recessive mutations, one of which is novel, of TMPRSS3 segregating in a six-generation extended family from Newfoundland. The spectrum of TMPRSS3 mutations is reviewed in the context of a genotype-phenotype correlation. Our study also revealed a longer isoform of TMPRSS3 with a hitherto unidentified exon encoding a signal peptide, which is expressed in several tissues. CONCLUSION: Mutations of TMPRSS3 contribute to hearing loss in many communities worldwide and account for 1.8% (8 of 449) of Pakistani families segregating congenital deafness as an autosomal recessive trait. The newly identified TMPRSS3 isoform e will be helpful in the functional characterization of the full length protein

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention